Shares of Zscaler, Inc. (NASDAQ:ZS) rose sharply in today’s pre-market trading after the company reported better-than-expected third-quarter earnings.…
Adaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next generation MAGE-A4 TCR T-cell therapy) produced on Galapagos' decentralized manufacturing platform